Expand NTRB Menu
NTRB MENU

NTRB Latest Press Releases

-- December 4, 2024 --

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 Globe Newswire 9:00 AM
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th Globe Newswire 7:00 AM

-- November 27, 2024 --

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa Abuse Deterrent Transdermal Technology Globe Newswire 7:00 AM

-- October 31, 2024 --

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application ACCESSWIRE 8:55 AM

-- October 17, 2024 --

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica ACCESSWIRE 7:01 AM

-- October 2, 2024 --

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 ACCESSWIRE 7:29 AM

-- September 24, 2024 --

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology ACCESSWIRE 9:56 AM
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse Globe Newswire 8:45 AM

-- September 20, 2024 --

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch ACCESSWIRE 6:50 AM

-- September 16, 2024 --

Nutriband Inc. Authorizes $1M Share Buyback Program ACCESSWIRE 4:02 PM

-- September 4, 2024 --

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 ACCESSWIRE 7:03 AM

-- July 19, 2024 --

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 ACCESSWIRE 7:57 AM

-- July 15, 2024 --

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology ACCESSWIRE 7:01 AM